Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Chinook Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +2 vs. Q4 2021
- Shares held
- 44.5M
- +1.13M (+2.6%) vs. Q4 2021
- Total value
- $727.3M
- +$19.9M (+2.8%) vs. Q4 2021
- New holders
- 14
- 39 more added
- Sold out
- 12
- 32 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 2,334,102 | $38.2M | 0.22% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,712,041 | $44.4M | 3.78% | +2,712,041 | New |
| Deep Track Capital, LP | 3,000,000 | $49.1M | 3.17% | +579,498+23.9% | Added |
| BlackRock Inc. | 3,054,997 | $50.0M | 0.00% | +67,066+2.2% | Added |
| Samsara BioCapital, LLC | 4,591,888 | $75.1M | 19.00% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −2,371,918−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −1,800,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −298,700−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −180,500−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −52,657−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −28,269−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −14,383−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −11,924−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,978−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,878−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −10,728−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |